LGALS9 and osteosarcoma: Additionally, Li et al. revealed Tregs enhance the immunosuppressive microenvironment in osteosarcoma through Gal9 secretion and activation of the Tim3/Gal9 signaling pathway, thereby reducing the efficacy of Th1-type immune responses and enhancing immune escape mechanisms (Li et al., 2017).